The purpose of this study was to evaluate the incidence, radiographic findings, relationship between presenting symptoms for treatment and drainage pattern, and treatment outcomes of hypoglossal canal dural arteriovenous fistula (HC-dAVF).
During a 16-year period, 238 patients underwent endovascular treatment for cranial dAVF at a single center. The incidence, radiographic findings, relationship between presenting symptoms for treatment and drainage pattern, and treatment outcomes of HC-dAVF were retrospectively evaluated.
The incidence of HC-dAVF was 4.2% (n = 10). Initial symptoms were tinnitus with headache (n = 6), tinnitus only (n = 1), ocular symptoms (n = 1), otalgia (n = 1), and congestive myelopathy (n = 1). Presenting symptoms requiring treatment included ocular symptoms (n = 4), hypoglossal nerve palsy (n = 4), aggravation of myelopathy (n = 1), and aggravation of tinnitus with headache (n = 1). While the affected HC was widened in 4 of 10 patients, hypersignal intensity on source images was conspicuous in all 7 patients who underwent MR angiography (MRA). All ocular symptoms and congestive myelopathy were associated with predominant drainage to superior ophthalmic or perimedullary veins due to antegrade drainage restriction. All patients who underwent transvenous coil embolization (n = 8) or transarterial N-butyl cyanoacrylate (NBCA) embolization (n = 1) improved without recurrence. One patient who underwent transarterial particle embolization had a recurrence 12 months posttreatment and was retreated with transvenous embolization.
The incidence of HC-dAVF was 4.2% of all cranial dAVF patients who underwent endovascular treatment. Source images of MRA helped to accurately diagnose HC-dAVF. More aggressive symptoms may develop as a result of a change in the predominant drainage route due to the development of venous stenosis or obstruction over time. Transvenous coil embolization appears to be the first treatment of choice.
Abbreviations used in this paper:dAVF = dural arteriovenous fistula; DSA = digital subtraction angiography; HC = hypoglossal canal; HC-dAVF = hypoglossal canal dural arteriovenous fistula; MRA = MR angiography; NBCA = N-butyl cyanoacrylate; 3D-TOF = 3D time-of-flight.
Address correspondence to: Byung Moon Kim, M.D., Ph.D., Division of Interventional Neuroradiology, Department of Radiology, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, 120-752, Seodaemun-gu, Seoul, South Korea. email: email@example.com.
Please include this information when citing this paper: published online May 31, 2013; DOI: 10.3171/2013.4.JNS121974.
ErnstRJGaskill-ShipleyMTomsickTAHallLCTewJMJrYehHS: Cervical myelopathy associated with intracranial dural arteriovenous fistula: MR findings before and after treatment. AJNR Am J Neuroradiol18:1330–13341997
HiraiTKorogiYIkushimaIShigematsuYMorishitaSYamashitaY: Usefulness of source images from three-dimensional time-of-flight MR angiography after treatment of cavernous dural arteriovenous fistulas. Radiat Med21:205–2092003
NoguchiKMelhemERKanazawaTKuboMKuwayamaNSetoH: Intracranial dural arteriovenous fistulas: evaluation with combined 3D time-of-flight MR angiography and MR digital subtraction angiography. AJR Am J Roentgenol182:183–1902004